These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 24486382)

  • 1. TRR469, a potent A(1) adenosine receptor allosteric modulator, exhibits anti-nociceptive properties in acute and neuropathic pain models in mice.
    Vincenzi F; Targa M; Romagnoli R; Merighi S; Gessi S; Baraldi PG; Borea PA; Varani K
    Neuropharmacology; 2014 Jun; 81():6-14. PubMed ID: 24486382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positive allosteric modulation of A
    Vincenzi F; Ravani A; Pasquini S; Merighi S; Gessi S; Romagnoli R; Baraldi PG; Borea PA; Varani K
    Neuropharmacology; 2016 Dec; 111():283-292. PubMed ID: 27639989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antinociceptive activity of α4β2* neuronal nicotinic receptor agonist A-366833 in experimental models of neuropathic and inflammatory pain.
    Nirogi R; Jabaris SL; Jayarajan P; Abraham R; Shanmuganathan D; Rasheed MA; Royapalley PK; Goura V
    Eur J Pharmacol; 2011 Oct; 668(1-2):155-62. PubMed ID: 21756895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antinociceptive effects of the selective CB2 agonist MT178 in inflammatory and chronic rodent pain models.
    Vincenzi F; Targa M; Corciulo C; Tabrizi MA; Merighi S; Gessi S; Saponaro G; Baraldi PG; Borea PA; Varani K
    Pain; 2013 Jun; 154(6):864-73. PubMed ID: 23518609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological effects of novel 2-amino-3-naphthoylthiophenes as allosteric enhancers of the A1 adenosine receptor.
    Baraldi PG; Romagnoli R; Pavani MG; Nuñez Mdel C; Tabrizi MA; Shryock JC; Leung E; Moorman AR; Uluoglu C; Iannotta V; Merighi S; Borea PA
    J Med Chem; 2003 Feb; 46(5):794-809. PubMed ID: 12593659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LPK-26, a novel kappa-opioid receptor agonist with potent antinociceptive effects and low dependence potential.
    Tao YM; Li QL; Zhang CF; Xu XJ; Chen J; Ju YW; Chi ZQ; Long YQ; Liu JG
    Eur J Pharmacol; 2008 Apr; 584(2-3):306-11. PubMed ID: 18353307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The combined predictive capacity of rat models of algogen-induced and neuropathic hypersensitivity to clinically used analgesics varies with nociceptive endpoint and consideration of locomotor function.
    Munro G; Storm A; Hansen MK; Dyhr H; Marcher L; Erichsen HK; Sheykhzade M
    Pharmacol Biochem Behav; 2012 May; 101(3):465-78. PubMed ID: 22366217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-antipyrine-3, 4-dichloromaleimide, an effective cyclic imide for the treatment of chronic pain: the role of the glutamatergic system.
    Quintão NL; da Silva GF; Antonialli CS; de Campos-Buzzi F; Corrêa R; Filho VC
    Anesth Analg; 2010 Mar; 110(3):942-50. PubMed ID: 20185671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-nociceptive and anti-allodynic activity of aliskiren in various pain models.
    Patel RB; Pawar VD; Prajapati KD; Sonara BM; Deshpande SS; Shah GB; Jain MR
    Eur J Pharmacol; 2013 May; 708(1-3):80-7. PubMed ID: 23545357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potentiation of analgesic efficacy but not side effects: co-administration of an α4β2 neuronal nicotinic acetylcholine receptor agonist and its positive allosteric modulator in experimental models of pain in rats.
    Zhu CZ; Chin CL; Rustay NR; Zhong C; Mikusa J; Chandran P; Salyers A; Gomez E; Simler G; Lewis LG; Gauvin D; Baker S; Pai M; Tovcimak A; Brown J; Komater V; Fox GB; Decker MW; Jacobson PB; Gopalakrishnan M; Lee CH; Honore P
    Biochem Pharmacol; 2011 Oct; 82(8):967-76. PubMed ID: 21620806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the spinal cord NR2B-containing NMDA receptors in the development of neuropathic pain.
    Qu XX; Cai J; Li MJ; Chi YN; Liao FF; Liu FY; Wan Y; Han JS; Xing GG
    Exp Neurol; 2009 Feb; 215(2):298-307. PubMed ID: 19046970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Cannabinoid CB1 Receptor-Positive Allosteric Modulator Reduces Neuropathic Pain in the Mouse with No Psychoactive Effects.
    Ignatowska-Jankowska BM; Baillie GL; Kinsey S; Crowe M; Ghosh S; Owens RA; Damaj IM; Poklis J; Wiley JL; Zanda M; Zanato C; Greig IR; Lichtman AH; Ross RA
    Neuropsychopharmacology; 2015 Dec; 40(13):2948-59. PubMed ID: 26052038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tapentadol, but not morphine, selectively inhibits disease-related thermal hyperalgesia in a mouse model of diabetic neuropathic pain.
    Christoph T; De Vry J; Tzschentke TM
    Neurosci Lett; 2010 Feb; 470(2):91-4. PubMed ID: 20026182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic administration of [Pyr
    Hajimashhadi Z; Aboutaleb N; Nasirinezhad F
    Neuropeptides; 2017 Feb; 61():15-22. PubMed ID: 27686494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antinociceptive, antiallodynic and antihyperalgesic effects of the 5-HT
    Sałat K; Kołaczkowski M; Furgała A; Rojek A; Śniecikowska J; Varney MA; Newman-Tancredi A
    Neuropharmacology; 2017 Oct; 125():181-188. PubMed ID: 28751195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The antinociceptive effect of reversible monoamine oxidase-A inhibitors in a mouse neuropathic pain model.
    Villarinho JG; Pinheiro Kde V; Pinheiro Fde V; Oliveira SM; Machado P; Martins MA; Bonacorso HG; Zanatta N; Fachinetto R; Ferreira J
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jul; 44():136-42. PubMed ID: 23419243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levodopa analgesia in experimental neuropathic pain.
    Cobacho N; De la Calle JL; González-Escalada JR; Paíno CL
    Brain Res Bull; 2010 Nov; 83(6):304-9. PubMed ID: 20813171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Positive Allosteric Modulator of the Adenosine A1 Receptor Selectively Inhibits Primary Afferent Synaptic Transmission in a Neuropathic Pain Model.
    Imlach WL; Bhola RF; May LT; Christopoulos A; Christie MJ
    Mol Pharmacol; 2015 Sep; 88(3):460-8. PubMed ID: 26104547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nefopam and ketoprofen synergy in rodent models of antinociception.
    Girard P; Verniers D; Coppé MC; Pansart Y; Gillardin JM
    Eur J Pharmacol; 2008 Apr; 584(2-3):263-71. PubMed ID: 18316069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism underlying anti-hyperalgesic and anti-allodynic properties of anomalin in both acute and chronic inflammatory pain models in mice through inhibition of NF-κB, MAPKs and CREB signaling cascades.
    Khan S; Shehzad O; Chun J; Kim YS
    Eur J Pharmacol; 2013 Oct; 718(1-3):448-58. PubMed ID: 23911882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.